DIRECT P-31 IMAGING IN HUMAN LIMB AND BRAIN
Citation
T. Ernst et al., DIRECT P-31 IMAGING IN HUMAN LIMB AND BRAIN, Journal of computer assisted tomography, 17(5), 1993, pp. 673-680
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging
SICI code
0363-8715(1993)17:5<673:DPIIHL>2.0.ZU;2-4
Abstract
Objective: This article describes two methods for direct imaging of th
e P-31-metabolites phosphocreatine (PCr) and inorganic phosphate (P(i)
) and their application in human brain and muscle. Materials and Metho
ds: All studies were performed on a 1.5 T whole-body GE Signa scanner,
using bird cage resonators double-tuned to P-31 and H-1. The pulse se
quence was based on a multiple slice, multiple echo imaging sequence.
Selection of the PCr signal was achieved either by selective excitatio
n or by the extensive chemical shift artifact in read direction. Exami
nations were done in two diabetic patients, in four patients with cere
bral neoplasms, and in several healthy subjects. Results: In calf musc
le, images showed uniform distribution of PCr in normal muscle; defici
ts corresponded to bony structures and neurovascular bundles. Repeated
exercise (dorsiflexion of the foot) led to selective loss of PCr in t
he anterior muscle compartment. A simultaneous increase in P(i) appear
ed as a spatially distinct map. Diabetic patients showed more severe c
hanges of PCr distribution in the calf muscle at rest and during much
milder exercise. Direct imaging in the human brain with chemical shift
selective excitation was completed in 5-30 min. In normal cerebral co
rtex, PCr was uniformly distributed around deficits marking the latera
l ventricles. Tumors exhibiting moderate to severe depletion of PCr ap
peared as well defined deficits in the PCr image. Conclusion: Direct i
maging of PCr and P(i), with or without selective excitation of PCr, w
as effective in the human brain and limb. The methods described should
lead to greatly improved fast phosphorus imaging. Clinical utility in
peripheral ischemia and in localized energy deficits in the brain of
patients with tumor, stroke, and other pathologies is anticipated.